Update on Phase 3 Librexia ACS Trial
Go back to Update on Phase 3 Librexia ACS Trial| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 60.56 -0.01 (0.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $60.57 | 52 Week High | $77.12 | |||
| Open | $61.00 | 52 Week Low | $49.03 | |||
| Day High | $61.56 | P/E | 39.32 | |||
| Day Low | $60.00 | EPS | $1.54 | |||
| Volume | 6,134,745 | |||||



